Barrow Hanley Mewhinney & Strauss LLC trimmed its stake in shares of Express Scripts Holding (NASDAQ:ESRX) by 8.6% during the fourth quarter, HoldingsChannel.com reports. The fund owned 17,095,646 shares of the company’s stock after selling 1,608,443 shares during the period. Express Scripts comprises about 1.9% of Barrow Hanley Mewhinney & Strauss LLC’s investment portfolio, making the stock its 23rd largest position. Barrow Hanley Mewhinney & Strauss LLC’s holdings in Express Scripts were worth $1,276,019,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors also recently modified their holdings of the company. SeaCrest Wealth Management LLC acquired a new stake in shares of Express Scripts during the fourth quarter worth $105,000. Bank of Nova Scotia Trust Co. acquired a new stake in shares of Express Scripts during the third quarter worth $120,000. Monroe Bank & Trust MI raised its holdings in shares of Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock worth $156,000 after acquiring an additional 970 shares during the period. Harvest Fund Management Co. Ltd acquired a new stake in shares of Express Scripts during the fourth quarter worth $183,000. Finally, Atlas Brown Inc. acquired a new stake in shares of Express Scripts during the fourth quarter worth $212,000. Institutional investors and hedge funds own 87.46% of the company’s stock.
In other news, VP Glen D. Stettin sold 3,449 shares of Express Scripts stock in a transaction dated Thursday, January 11th. The shares were sold at an average price of $81.00, for a total value of $279,369.00. Following the completion of the transaction, the vice president now owns 33,715 shares of the company’s stock, valued at approximately $2,730,915. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Glen D. Stettin sold 3,448 shares of Express Scripts stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total transaction of $262,048.00. The disclosure for this sale can be found here. In the last three months, insiders sold 17,001 shares of company stock valued at $1,249,505. Insiders own 0.68% of the company’s stock.
Express Scripts Holding (ESRX) opened at $75.23 on Monday. Express Scripts Holding has a 12-month low of $55.80 and a 12-month high of $83.49. The company has a market cap of $42,610.00, a PE ratio of 12.50, a PEG ratio of 0.81 and a beta of 0.93. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61.
Express Scripts declared that its Board of Directors has approved a share repurchase plan on Monday, December 18th that permits the company to repurchase 45,000,000 shares. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company’s board of directors believes its stock is undervalued.
Express Scripts Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.